Detalhe da pesquisa
1.
Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence.
Ann Surg Oncol
; 29(9): 5568-5577, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35583694
2.
Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study.
Ann Oncol
; 28(7): 1569-1575, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28444114
3.
ASO Visual Abstract: Radical Resection in Enteropancreatic Neuroendocrine Tumors-Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence.
Ann Surg Oncol
; 29(9): 5580-5581, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35789310
4.
Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study.
Ann Oncol
; 30(12): 2010, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31406974
5.
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours.
Eur J Nucl Med Mol Imaging
; 40(5): 800-16, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23389427
6.
Novel therapeutic agents for the treatment of gastroenteropancreatic neuroendocrine tumors.
Horm Metab Res
; 43(12): 844-53, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22105475
7.
Effect of everolimus on the pharmacokinetics of octreotide long-acting repeatable in patients with advanced neuroendocrine tumors: An analysis of the randomized phase III RADIANT-2 trial.
Clin Pharmacol Ther
; 101(4): 462-468, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28032910
8.
[Gastrointestinal neuroendocrine neoplasias: novel individualized therapeutic strategies]. / Neuroendokrine Neoplasien im Gastrointestinaltrakt: Neue Individualisierte Therapieansätze.
Dtsch Med Wochenschr
; 136(36): 1801-6, 2011 Sep.
Artigo
em Alemão
| MEDLINE | ID: mdl-21882138
9.
Adrenomedullin is a novel marker of tumor progression in neuroendocrine carcinomas.
Horm Metab Res
; 38(2): 112-8, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16523412
10.
Impact of growth hormone on central nervous activity, vigilance, and tiredness after short-term therapy in growth hormone-deficient adults.
Horm Metab Res
; 35(2): 114-9, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12734792